The global antimicrobial resistance diagnostics market size was estimated at USD 3.42 billion in 2025 and is expected to reach USD 4.68 billion by 2033, growing at a CAGR of 4.08% from 2026 to 2033. The high prevalence of pathogens such as Streptococcus pneumoniae, MRSA, and C. difficile... Read More »
December 2025The global molecular diagnostics market size was estimated at USD 18.85 billion in 2025 and is projected to reach USD 25.59 billion by 2033, growing at a CAGR of 4.06% from 2026 to 2033. Key drivers of this growth include ongoing technological advancements, a steadily aging population, a... Read More »
December 2025The global biological safety testing products & services market size was estimated at USD 5.38 billion in 2025 and is projected to reach USD 12.09 billion by 2033, growing at a CAGR of 10.69% from 2026 to 2033. The growing prevalence of target diseases and rising production of next-g... Read More »
December 2025The global clinical laboratory services market size was valued at USD 224.35 billion in 2025 and is expected to reach USD 308.24 billion by 2033, expanding at a CAGR of 4.28% from 2026 to 2033. The market is witnessing growth due to factors such as the increasing burden of chronic diseas... Read More »
December 2025The global rapid point-of-care testing for sickle cell anemia market size was estimated at USD 328.69 million in 2025 and is projected to reach USD 735.35 million by 2033, growing at a CAGR of 10.91% from 2026 to 2033. The market is driven by advancements in diagnostic technology and the... Read More »
December 2025The global lateral flow assays (LFA) market size was estimated at approximately USD 10.17 billion in 2025 and is projected to reach USD 17.44 billion by 2033, growing at a CAGR of 7.41% from 2026 to 2033, driven by the increasing demand for rapid and cost-effective diagnostic solutions, ... Read More »
December 2025The global Alzheimer's disease diagnostics market size was estimated at USD 9.22 billion in 2025 and is expected to reach USD 21.54 billion by 2033, projected to grow at a CAGR of 11.23% from 2026 to 2033. Increasing prevalence of Alzheimer’s Disease (AD), growing use of biomarkers... Read More »
December 2025The Middle East diagnostic reagents for infectious diseases market size was estimated at USD 77.92 million in 2024, and is projected to reach USD 158.14 million by 2033, growing at a CAGR of 7.6% from 2025 to 2033. The market is being driven by an increase in regulatory authorizations fo... Read More »
December 2025The global pan-genomic & multi-gene panel testing market size was estimated at USD 8.96 billion in 2024 and is projected to reach USD 23.19 billion by 2033, growing at a CAGR of 11.37% from 2025 to 2033, driven by driven by clinical adoption in oncology and precision medicine and inc... Read More »
December 2025The Middle East liquid biopsy market size was valued at USD 104.76 million in 2024 and is projected to reach USD 233.95 billion by 2033, growing at a CAGR of 9.28% from 2025 to 2033. The market is driven by increased emphasis on early detection and population-level screening initiatives ... Read More »
November 2025The global hematocrit testing market size was estimated at USD 1.25 billion in 2024 and is projected to reach USD 2.01 billion by 2033, growing at a CAGR of 5.30% from 2025 to 2033, driven by a rising prevalence of hematological and chronic diseases, including anemia, blood loss monitori... Read More »
November 2025The global antinuclear antibody test market size was estimated at USD 1.76 billion in 2024 and is projected to reach USD 5.47 billion by 2033, growing at a CAGR of 13.49% from 2025 to 2033. The market growth is accelerated by advancements in antinuclear antibody test (ANA) diagnostics, a... Read More »
November 2025The global endocrine function diagnostics market size was estimated at USD 13.16 billion in 2024 and is projected to reach USD 26.23 billion by 2033, growing at a CAGR of 8.0% from 2025 to 2033. The growing prevalence of endocrine disorders, strong shift towards precision diagnostics, an... Read More »
November 2025The global HPV testing and Pap test market size was estimated at USD 3.34 billion in 2024 and is projected to reach USD 6.18 billion by 2033, growing at a CAGR of 7.2% from 2025 to 2033. Technological advancements in testing products, increasing prevalence of cervical cancer, and governm... Read More »
November 2025The global hereditary testing market size was estimated at USD 16.16 billion in 2024 and is projected to reach USD 52.66 billion by 2033, growing at a CAGR of 14.42% from 2025 to 2033, due to the increasing prevalence of genetic disorders and related chronic conditions. As mor... Read More »
November 2025The global cellular health screening market size was estimated at USD 3.30 billion in 2024 and is projected to reach USD 7.41 billion by 2033, growing at a CAGR of 9.5% from 2025 to 2033. An aging global population and the prevalence of age-related chronic diseases drive the market growt... Read More »
November 2025The global CRISPR-based POC diagnostics market size was estimated at USD 502.64 million in 2024 and is projected to reach USD 1,786.56 million by 2033, growing at a CAGR of 15.41% from 2025 to 2033. The market is expanding as diagnostic capabilities shift closer to the point of care, sup... Read More »
November 2025The global mycoplasma testing market size was estimated at USD 1.03 billion in 2024 and is expected to reach USD 2.81 billion in 2033, growing at a CAGR of 11.94% from 2025 to 2033. The rising investments in research and development (R&D) across the life sciences sector are a signifi... Read More »
November 2025The global diagnostic reagents for infectious diseases market size was estimated at USD 3,475.31 million in 2024 and is projected to reach USD 8,079.07 million by 2033, growing at a CAGR of 9.30% from 2025 to 2033. The market is primarily driven by the increasing prevalence of respirator... Read More »
November 2025The global rapid pathogen detection diagnostics market size was estimated at USD 21.05 billion in 2024 and is projected to reach USD 30.90 billion by 2033, growing at a CAGR of 4.48% from 2025 to 2033. The growth is driven by growing demand for point-of-care testing, rising awareness and... Read More »
November 2025